Replimune Group
Replimune is a Woburn, Massachusetts-based biotechnology company founded in 2015 that develops and commercializes oncolytic immunotherapies for cancer. Its RPx platform uses engineered herpes simplex viruses to kill tumor cells and stimulate systemic anti-tumor immune responses. Its first commercial therapy is TUDRIQEV for advanced melanoma.
Key facts
| Legal Name | Replimune Group, Inc. |
|---|---|
| Company Operating Status | Active |
| Full Address | 18 Commerce Way Woburn, MA 01801 United States |
| Stock Symbol | REPL |
| Ticker Symbol | REPL |
Open roles at Replimune Group
- Manager, FP&A
- Analyst I, Analytical Services
- Associate Director, Analytical Services
- Sr. Medical Science Liaison II - New England
- Senior Engineer, Technical Operations
- Senior Associate, Clinical Supply Chain
- Associate Director, Process Development
- Director, Data Analytics and Reporting
- Senior Quality Control, Microbiology Analyst
- QC Microbiology Technician
- Senior Quality Control Analyst
- Quality Control Analyst I
Browse Replimune Group roles by location: 🌍 Remote
Land a role at Replimune Group
publicOpen roles & company overview
Every live role, the locations Replimune Group hires across, and the company facts — all above.
membersAlerts & tailored applications
An email the day Replimune Group posts a role, a cover letter and résumé bullets tailored to each one, and one-click apply.
Get startedEmail & phone for Replimune Group are shown to signed-in members. Sign in →